Antibiotic resistance patterns in Pseudomonas aeruginosa: an 8-year surveillance study in a French hospital

被引:11
作者
Bert, F
LambertZechovsky, N
机构
[1] Service de Microbiologie, Hôpital Beaujon, 92110 Clichy
关键词
Pseudomonas aeruginosa; antibiotic resistance; beta-lactams; aminoglycosides; ciprofloxacin; O serotype;
D O I
10.1016/S0924-8579(97)00033-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The susceptibility to ticarcillin, piperacillin, ceftazidime, aztreonam, tobramycin, amikacin, ciprofloxacin and fosfomycin of 3876 strains of Pseudomonas aeruginosa isolated during the period 1989-1996 in a French hospital was investigated. The most frequently active agents were amikacin and ceftazidime to which 13.3% and 16.1% of the isolates were resistant. Analysis of beta-lactam susceptibility patterns suggested that cephalosporinase derepression and intrinsic resistance were the predominant underlying mechanisms. There was a trend towards a decline in susceptibility to beta-lactams, aminoglycosides and ciprofloxacin over time. Multiresistance was frequent, mainly in 011 and 012 isolates. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 25 条
[1]   MARKED INCREASE OF PSEUDOMONAS-AERUGINOSA SEROTYPE-012 IN BELGIUM SINCE 1982 [J].
ALLEMEERSCH, D ;
BEUMER, J ;
DEVLEESCHOUWER, M ;
DEMAEYER, S ;
DONY, J ;
GODARD, C ;
OSTERRIETH, P ;
PITHSY, A ;
VANDERAUWERA, P ;
VANPOPPEL, H ;
VERSCHRAEGEN, G ;
WEGGE, M ;
WILDEMAUWE, C .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (02) :265-269
[2]  
Bert F, 1996, PATHOL BIOL, V44, P329
[3]   IMIPENEM RESISTANCE IN PSEUDOMONAS-AERUGINOSA RESULTING FROM DIMINISHED EXPRESSION OF AN OUTER-MEMBRANE PROTEIN [J].
BUSCHER, KH ;
CULLMANN, W ;
DICK, W ;
OPFERKUCH, W .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (05) :703-708
[4]   MECHANISMS OF RESISTANCE TO BETA-LACTAM ANTIBIOTICS AMONGST PSEUDOMONAS-AERUGINOSA ISOLATES COLLECTED IN THE UK IN 1993 [J].
CHEN, HY ;
YUAN, M ;
LIVERMORE, DM .
JOURNAL OF MEDICAL MICROBIOLOGY, 1995, 43 (04) :300-309
[5]   NATIONAL SURVEY OF SUSCEPTIBILITY TO ANTIMICROBIALS AMONGST CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA [J].
CHEN, HY ;
YUAN, M ;
IBRAHIMELMAGBOUL, IB ;
LIVERMORE, DM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1995, 35 (04) :521-534
[6]   HOSPITAL OUTBREAKS CAUSED BY PSEUDOMONAS-AERUGINOSA - IMPORTANCE OF SEROGROUP O-11 [J].
FARMER, JJ ;
WEINSTEIN, RA ;
ZIERDT, CH ;
BROKOPP, CD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1982, 16 (02) :266-270
[7]  
Giammanco A, 1985, Eur J Epidemiol, V1, P104, DOI 10.1007/BF00141801
[8]  
GILMORE DS, 1982, J CLIN MICROBIOL, V16, P856, DOI 10.1128/JCM.16.5.856-860.1982
[9]   INTRINSIC ANTIBIOTIC-RESISTANCE OF PSEUDOMONAS-AERUGINOSA [J].
HANCOCK, REW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (06) :653-656
[10]   IMPORTANCE OF CARBENICILLIN AND GENTAMICIN CROSS-RESISTANT SEROTYPE 0-12 PSEUDOMONAS-AERUGINOSA IN 6 ATHENS HOSPITALS [J].
LEGAKIS, NJ ;
KOUKOUBANIS, N ;
MALLIARA, K ;
MICHALITSIANOS, D ;
PAPAVASSILIOU, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (03) :300-303